BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15887247)

  • 21. BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.
    Bock VL; Lyons JG; Huang XX; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM
    Br J Dermatol; 2011 Jun; 164(6):1221-7. PubMed ID: 21564052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
    Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E
    Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
    Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
    Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes.
    Zhang Y; Cheng MB; Zhang YJ; Zhong X; Dai H; Yan L; Wu NH; Zhang Y; Shen YF
    Cell Res; 2010 Dec; 20(12):1345-60. PubMed ID: 21079652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.
    Alessio N; Squillaro T; Cipollaro M; Bagella L; Giordano A; Galderisi U
    Oncogene; 2010 Oct; 29(40):5452-63. PubMed ID: 20697355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When the SWI/SNF complex remodels...the cell cycle.
    Muchardt C; Yaniv M
    Oncogene; 2001 May; 20(24):3067-75. PubMed ID: 11420722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. brg1: a putative murine homologue of the Drosophila brahma gene, a homeotic gene regulator.
    Randazzo FM; Khavari P; Crabtree G; Tamkun J; Rossant J
    Dev Biol; 1994 Jan; 161(1):229-42. PubMed ID: 7904967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
    Raab JR; Runge JS; Spear CC; Magnuson T
    Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1.
    Ishida M; Tanaka S; Ohki M; Ohta T
    Genes Cells; 2004 May; 9(5):419-28. PubMed ID: 15147271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
    Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
    Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.
    Wiley MM; Muthukumar V; Griffin TM; Griffin CT
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
    Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
    J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex.
    Muchardt C; Bourachot B; Reyes JC; Yaniv M
    EMBO J; 1998 Jan; 17(1):223-31. PubMed ID: 9427756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repression of GR-mediated expression of the tryptophan oxygenase gene by the SWI/SNF complex during liver development.
    Inayoshi Y; Kaneoka H; Machida Y; Terajima M; Dohda T; Miyake K; Iijima S
    J Biochem; 2005 Oct; 138(4):457-65. PubMed ID: 16272140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted knockout of BRG1 potentiates lung cancer development.
    Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D
    Cancer Res; 2008 May; 68(10):3689-96. PubMed ID: 18483251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes.
    Xu Y; Zhang J; Chen X
    J Biol Chem; 2007 Dec; 282(52):37429-35. PubMed ID: 17938176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.
    Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H
    Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.
    Matsubara D; Kishaba Y; Ishikawa S; Sakatani T; Oguni S; Tamura T; Hoshino H; Sugiyama Y; Endo S; Murakami Y; Aburatani H; Fukayama M; Niki T
    Cancer Sci; 2013 Feb; 104(2):266-73. PubMed ID: 23163725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.
    Kothandapani A; Gopalakrishnan K; Kahali B; Reisman D; Patrick SM
    Exp Cell Res; 2012 Oct; 318(16):1973-86. PubMed ID: 22721696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.